Published:
Friday, May 24, 2013 10:17 AM PDT
One of the biopharmaceutical companies that has been lagging the stellar performance of its peers is Exelixis (NADSAQ: EXEL), developer of the compound cabozantinib. Cabo, which was FDA approved last year for the treatment of medullary thyroid cancer (MTC), is now being marketed under the trade name COMETRIQ. In the company’s reported Q1 2013 earnings release on May 7th, the company was able to present some early results for the drug’s performance on the open market although it’s difficult to accurately interpret a drug’s intrinsic monetary potential with only a few weeks of sales data and estimates on the drug’s penetration into a market.
Published:
Friday, May 24, 2013 7:21 AM PDT
If it's not, LeapFrog Enterprises, Inc. (NYSE:LF) should certainly be on the radars of Mattel, Inc. (NASDAQ:MAT) and Hasbro, Inc. (NASDAQ:HAS).
Published:
Friday, May 24, 2013 4:22 AM PDT
The latest good news coming out of the Williston Basin’s Bakken and Three Forks formations plus players there like Samson Oil & Gas Limited (SSN), Nuverra Environmental Solutions Inc (NES) and Norstra Energy, Inc (NORX).
» Read More
Published:
Thursday, May 23, 2013 11:24 PM PDT
Move over Sony Corporation (SNE) or Canon Inc. (CAJ): A quick look a Japanese small cap or mid cap stocks Internet Initiative Japan Inc. (IIJI), Advantest Corp (ATE) and Konami Corp (KNM) verses small cap Japan ETFs.
» Read More
Published:
Thursday, May 23, 2013 12:50 PM PDT
VIVUS, Inc. (NASDAQ:VVUS) has been spinning its wheels for quite some time, but today's breakout is apt to create the very melt-up the market was waiting to see.
Published:
Thursday, May 23, 2013 11:08 AM PDT
Amarin, on the whole, seems to have fallen out of favor in the biotech investment community. This may change as we head closer to December 20th (or after an unexpected announcement), but without a tangible piece of news that can positively affect Vascepa’s sales figures or its financial valuation don’t expect much more than a continuation of what we’ve seen this year.
Published:
Thursday, May 23, 2013 7:54 AM PDT
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) is rolling again. Take it at face value.
Published:
Thursday, May 23, 2013 2:00 AM PDT
Sporting goods stock Cabela’s Inc (CAB) is said to be the benefactor Obama’s gun control policies but that’s only part of the picture. Plus, comparing CAB’s performance with large cap peer Big 5 Sporting Goods Corporation (BGFV) and small caps Dicks Sporting Goods Inc (DKS) and Hibbett Sports, Inc. (HIBB).
» Read More
Published:
Wednesday, May 22, 2013 7:52 AM PDT
Small cap LeapFrog Enterprises, Inc. (LF) offers good growth potential in digital learning space for children of all ages plus its looking rather undervalued with little debt.
» Read More
Published:
Tuesday, May 21, 2013 1:42 PM PDT
The upcoming Phase II trial, which is expected to begin before the end of the H1 2013, should be watched closely since it will demonstrate to Neuralstem investors and the rest of the market whether or not the company can replicate the implied efficacy in the Phase I studies with NSI-566.
